GPCR
Structure·NASDAQ
--
--(--)
--
--(--)
2.07 / 10
Underperform
The fundamental assessment of Structure Therapeutics is concerning, scoring only 2.1/10. Key weaknesses include a negative Revenue-MV (-0.2574) and a sub-par Gross Profit Margin of 36.70%, while Cash-MV and Profit-MV show marginal strength. Historical back-tests indicate limited upside potential, with one-month returns ranging from -0.54% to 7.79% across different factors, reinforcing a guarded outlook.
Analysis Checks(6/10)
Revenue-MV
Value-0.26
Score1/3
Weight12.80%
1M Return5.20%
Value-0.26
Score1/3
Weight12.80%
1M Return5.20%
Gross profit margin (%)
Value36.70
Score1/3
Weight-0.99%
1M Return-0.54%
Value36.70
Score1/3
Weight-0.99%
1M Return-0.54%
PB-ROE
Value0.88
Score0/3
Weight8.75%
1M Return3.56%
Value0.88
Score0/3
Weight8.75%
1M Return3.56%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight1.63%
1M Return0.86%
Value7979.42
Score3/3
Weight1.63%
1M Return0.86%
Cash-MV
Value-0.07
Score2/3
Weight19.19%
1M Return7.73%
Value-0.07
Score2/3
Weight19.19%
1M Return7.73%
Inventory turnover ratio
Value47.85
Score3/3
Weight11.25%
1M Return5.26%
Value47.85
Score3/3
Weight11.25%
1M Return5.26%
Profit-MV
Value0.46
Score2/3
Weight19.17%
1M Return7.79%
Value0.46
Score2/3
Weight19.17%
1M Return7.79%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.24%
1M Return1.15%
Value1.78
Score2/3
Weight2.24%
1M Return1.15%
Asset-MV
Value-0.50
Score1/3
Weight23.24%
1M Return8.74%
Value-0.50
Score1/3
Weight23.24%
1M Return8.74%
Net profit / Total profit (%)
Value100.20
Score2/3
Weight2.71%
1M Return1.28%
Value100.20
Score2/3
Weight2.71%
1M Return1.28%
Revenue-MV
Value-0.26
Score1/3
Weight12.80%
1M Return5.20%
Value-0.26
Score1/3
Weight12.80%
1M Return5.20%
Inventory turnover ratio
Value47.85
Score3/3
Weight11.25%
1M Return5.26%
Value47.85
Score3/3
Weight11.25%
1M Return5.26%
Gross profit margin (%)
Value36.70
Score1/3
Weight-0.99%
1M Return-0.54%
Value36.70
Score1/3
Weight-0.99%
1M Return-0.54%
Profit-MV
Value0.46
Score2/3
Weight19.17%
1M Return7.79%
Value0.46
Score2/3
Weight19.17%
1M Return7.79%
PB-ROE
Value0.88
Score0/3
Weight8.75%
1M Return3.56%
Value0.88
Score0/3
Weight8.75%
1M Return3.56%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.24%
1M Return1.15%
Value1.78
Score2/3
Weight2.24%
1M Return1.15%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight1.63%
1M Return0.86%
Value7979.42
Score3/3
Weight1.63%
1M Return0.86%
Asset-MV
Value-0.50
Score1/3
Weight23.24%
1M Return8.74%
Value-0.50
Score1/3
Weight23.24%
1M Return8.74%
Cash-MV
Value-0.07
Score2/3
Weight19.19%
1M Return7.73%
Value-0.07
Score2/3
Weight19.19%
1M Return7.73%
Net profit / Total profit (%)
Value100.20
Score2/3
Weight2.71%
1M Return1.28%
Value100.20
Score2/3
Weight2.71%
1M Return1.28%
Is GPCR undervalued or overvalued?
- GPCR scores 2.07/10 on fundamentals and holds a Premium valuation at present. Backed by its -21.31% ROE, 0.00% net margin, -24.59 P/E ratio, 6.73 P/B ratio, and -69.44% earnings growth, these metrics solidify its Underperform investment rating.
